Cover Image

Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a fast-spreading viral pathogen and poses a serious threat to human health. New SARS-CoV-2 variants have been arising worldwide; therefore, is necessary to explore more therapeutic options. The interaction of the viral spike (S) pro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Timoteo Delgado-Maldonado (Author), Alonzo González-González (Author), Adriana Moreno-Rodríguez (Author), Virgilio Bocanegra-García (Author), Ana Verónica Martinez-Vazquez (Author), Erick de Jesús de Luna-Santillana (Author), Gerard Pujadas (Author), Guadalupe Rojas-Verde (Author), Edgar E. Lara-Ramírez (Author), Gildardo Rivera (Author)
Format:	Book
Published:	MDPI AG, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning
by: Lev Shapira, et al.
Published: (2022)

Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model
by: Balkrishna A, et al.
Published: (2021)

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor
by: Taizhen Liang, et al.
Published: (2021)

Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
by: Sara Zareei, et al.
Published: (2022)

Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2
by: Israa Mohamed Shamkh, et al.
Published: (2021)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
by: Kaleb B. Tsegay, et al.
Published: (2021)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021)

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein
by: Abdolkarim Sheikhi, et al.
Published: (2021)

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
by: Balkrishna A, et al.
Published: (2021)

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
by: Paolo Coghi, et al.
Published: (2021)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020)

SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor
by: Yiqun Li, et al.
Published: (2023)

Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders
by: Sung-Ting Chuang, et al.
Published: (2022)

In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells
by: Rahul Dilawari, et al.
Published: (2024)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
by: Urszula Tyrankiewicz, et al.
Published: (2021)

Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2" [J Mol Docking. 2021;1(2):1-14]
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
by: Damir Bojadzic, et al.
Published: (2021)

Antrodia cinnamomea May Interfere with the Interaction Between ACE2 and SARS-CoV-2 Spike Protein in vitro and Reduces Lung Inflammation in a Hamster Model of COVID-19
by: Li LH, et al.
Published: (2023)

In Vitro Effect of <i>Taraxacum officinale</i> Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants
by: Hoai Thi Thu Tran, et al.
Published: (2021)

Role of ACE and ACE-2 in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart
by: Vimal Kumar, et al.
Published: (2022)

Profiling ACE2 and TMPRSS2 expression in sinonasal mucosa
by: Michael E Price, et al.
Published: (2022)

Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats
by: Xue Mei, et al.
Published: (2023)

Is Covid-19 Severity Associated With ACE2 Degradation?
by: Ugo Bastolla, et al.
Published: (2022)

Serum Ace and Ace I/D Polymorphism: Risk of Type 2 Diabetes with and Without Nephropathy in Pakistani Cohort
by: Hiba Bano, et al.
Published: (2022)

Vitamin D improves hepatic alterations in ACE1 and ACE2 expression in experimentally induced metabolic syndrome
by: Sara Mohater, et al.
Published: (2023)

Investigation of Interactions Between Sedative, Analgesic and Anaesthetic Drugs with SARS-CoV-2, ACE-2 and SARS-CoV-2- ACE-2 Complex by Molecular Docking Method
by: Evren Büyükfırat, et al.
Published: (2021)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
by: Jose A. Jimenez Ruiz, et al.
Published: (2022)

Expression pattern and function of SARS-CoV-2 receptor ACE2
by: Ruiting Li, et al.
Published: (2021)

Salivary ACE2 and TMPRSS2 link to periodontal status and metabolic parameters
by: Dan Zhao, et al.
Published: (2022)

Effect of ACE, ACE2 and CYP11B2 gene polymorphisms and noise on essential hypertension among steelworkers in China: a case-control study
by: Xiaohong Zhang, et al.
Published: (2022)

Serum levels of ACE2 are higher in patients with obesity and diabetes
by: Valur Emilsson, et al.
Published: (2021)

Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling
by: Acharya Balkrishna, et al.
Published: (2022)

Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System
by: Farideh Zafari Zangeneh
Published: (2022)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015)

Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
by: Ceren Guney, et al.
Published: (2021)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021)

Angiotensin converting enzyme 2 (ACE2) - the major receptor for SARS-CoV-2 virus
by: Sonia Frankowska, et al.
Published: (2021)

Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
by: Meichen Yan, et al.
Published: (2021)

Study on the Clinical Significance of ACE2 and Its Age-Related Expression
by: Gu J, et al.
Published: (2021)